Article info

Protocol
Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)

Authors

  1. Correspondence to Dr Christophe Taoum; christophe.taoum{at}icm.unicancer.fr
View Full Text

Citation

Taoum C, Carrier G, Jarlier M, et al
Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)

Publication history

  • Received February 11, 2022
  • Accepted October 24, 2022
  • First published December 2, 2022.
Online issue publication 
December 02, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.